UNLV Retrospective Theses & Dissertations
1-1-2008

Activation of platelet-activating factor acetylhydrolase by
proinflammatory mediators
Mohammed Abdel-al
University of Nevada, Las Vegas

Follow this and additional works at: https://digitalscholarship.unlv.edu/rtds

Repository Citation
Abdel-al, Mohammed, "Activation of platelet-activating factor acetylhydrolase by proinflammatory
mediators" (2008). UNLV Retrospective Theses & Dissertations. 2334.
http://dx.doi.org/10.25669/6n4v-n7g4

This Thesis is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV
with permission from the rights-holder(s). You are free to use this Thesis in any way that is permitted by the
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself.
This Thesis has been accepted for inclusion in UNLV Retrospective Theses & Dissertations by an authorized
administrator of Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu.

ACTIVATION OF PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE BY
PROINFLAMMATORY MEDIATORS

by

Mohammed Abdel-al
Bachelor o f Science
University o f California, Riverside
2006

A thesis submitted in partial fulfillment
o f the requirements for the

Master of Science Degree in Biochemistry
Department of Chemistry
College of Sciences

Graduate College
University of Nevada, Las Vegas
August 2008

UMI Number: 1460454

INFORMATION TO USERS

The quality of this reproduction is dependent upon the quality of the copy
submitted. Broken or indistinct print, colored or poor quality illustrations and
photographs, print bleed-through, substandard margins, and improper
alignment can adversely affect reproduction.
In the unlikely event that the author did not send a complete manuscript
and there are missing pages, these will be noted. Also, If unauthorized
copyright material had to be removed, a note will indicate the deletion.

UMI
UMI Microform 1460454
Copyright 2009 by ProQuest LLC.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest LLC
789 E. Eisenhower Parkway
PC Box 1346
Ann Arbor, Ml 48106-1346

Thesis Approval
The Graduate College
University of Nevada, Las Vegas

J u l y 21

-,20_ 08

The Thesis prepared by

Mohammed A b d el - al
Entitled

A c t i v a t i o n o f P l a t e l e t - A c t i v a t i n g F a c t o r Acetyl h y d r o l a s e by
P r o i n f 1ammatory M ed ia to r s

is approved in partial fulfillment of the requirements for the degree of

M as ter o f S c ie n c e in B io c h e m i s t r y

examination Commitfèé‘Co-Chair

Examination Committee Chair

Dean of the Graduate College

Examination Committee Member

Examination Committee Member

/

^

f d L
Graduate College Faculty Representative

11

ABSTRACT
Activation of Platelet Activating Factor Acetylhydrolase by Proinflammatory
Mediators
by
Mohammed Abdel-al
Dr. Katherine M. Howard, Assistant Professor o f Biomedical Sciences
Dr. Ronald K. Gary, Associate Professor o f Biochemistry
Examination Committee Co-Chairs
University o f Nevada, Las Vegas
Inflammation is a highly complex and beneficial response o f the host innate
immune system often characterized by redness or swelling o f the infected area as a result
o f an injurious stimulus. The principal purpose o f the inflammatory response is to rid the
infected area of the noxious stimulus and hasten host recovery. Though the inflammatory
response is both necessary and beneficial, if left unregulated, it can exact a devastating
toll on the host. Thus, an understanding o f the various mediators that are able to evoke an
inflammatory response and the signaling o f these mediators is crucial. One such
mediator, central in initiating an inflammatory response, is the biologically active
phospholipid

platelet-activating

factor

(PAF,

l-0-alkyl-2-acetyl-.î«-glycero-3-

phosphocholine). This phospholipid is converted to its biologically inactive form by a
calcium-independent phospholipase A 2 called PAF acetylhydrolase (PAF-AH). Thus, the
action o f PAF-AH provides a mechanism by which to hinder the propagation o f an
inflammatory response. In this study, the proinflammatory mediators, lipopolysaccharide
(LPS), PAF, and tumor necrosis factor- a (TNF-a) were investigated for their ability to

in

upregulate PAF-AH expression. The cellular signaling pathways activated by these
mediators were also investigated. We have demonstrated the ability o f LPS, PAF, and
TNF-a to upregulate PAF-AH levels. Further, we showed that the LPS-induced
upregulation of PAF-AH levels is partially p38MAPK-dependent. The remaining LPSinduced signaling is mediated through the PAF receptor. The TNF-a and PAF-induced
upregulation o f PAF-AH levels is not p38MAPK dependent and the PAF acetylhydrolase
induction observed may be the result of increased PAF production or signaling through
separate pathway(s). We further demonstrate the ability of reactive oxygen species to
induce the expression PAF acetylhydrolase.
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CHAPTER 1

INTRODUCTION
I . I Background and Significance
Inflammation is an elaborate, complicated, and highly integrated biological
response of vascularized tissue to insult or injury. The principal and beneficial purpose
o f inflammation is to contain and remove offending microorganisms and necrotic tissue
that may ensue as a result o f some pathological trigger (I). While this is essential, the
inflammatory process can also cause severe tissue injury and dysfunction via the same,
but often accentuated, physiologic mechanisms (I).

The inability to exact an

appropriately regulated inflammatory response has led to 40 million inflammatory
disease related cases in the United States today ranging from asthma to inflammatory
bowel disease (2). Thus, a thorough understanding o f the potent pro-inflammatory
mediators that are essential in eliciting an inflammatory response is crucial. One such
mediator, central in the inflammatory response, is the phospholipid platelet-activating
factor (PAF, I-0-alkyl-2-acetyl-s'«-glycero-3-phosphocholine). The chemical structure of
PAF is shown in Figure I (3).
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Figure 1: Structure of Platelet Activating Factor. Platelet Activating Factor (PAF, 10-alkyl-2-acetyl-.s'77-glycero-3-phosphocholine) is a potent proinflammatory phospholipid
that is central in exacting an inflammatory response. From: King, M. W. (2008) Lipid
Metabolism. Illinois

Many isoforms o f PAF exist with modifications in chain length and functionalities at
both the sn-\ and sn-2 positions as seen in Figure 2. The most biologically potent form o f
PAF consists o f a methylene chain length o f sixteen carbons at the sn-\ position and an
acetate moiety at the sn-2 position. PAF, itself, has been implicated in many
inflammatory disease states affecting cardiovascular, gastrointestinal, pulmonary, hepatic
and renal systems (2). PAF was originally identified through antigen stimulation o f IgE
sensitized rabbit basophils. The phospholipid was first isolated by its ability to aggregate
platelets and was given the name platelet-activating factor (4). The structure o f PAF was
determined by Demopoulos et al. in 1979 (5).
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Figure 2; Enzymatic action of PAF acetylhydrolase and Variations in PAF
Structure: A. Though the inflammatory response is both necessary and beneficial, if left
unregulated, it can lead to the detriment o f the organism. A class o f enzymes categorized
as calcium independent phospholipase A 2 S called PAF acetylhydrolases help
downregulate the inflammatory response. Upon exposure to an inflammatory agonist,
endothelial cells are stimulated to generate PAF. PAF is then free to signal through its Gprotein coupled receptor on various cell types o f the hematpoietic cell lineage and induce
an appropriate inflammatory response. By their action o f PAF acetylhydrolases, the
acetate moiety at the sn-2 position of PAF is cleaved generating the biologically inactive
lyso-PAF thereby limiting the progression o f the inflammatory response. B. Possible
variations at the sn-2 position which are characteristic o f PAF mimetics and are often
induced through action of reactive oxygen species. Figure 2A is from Castro Faria Neto,
FI. C., Stafforini, D. M., Prescott, S. M., and Zimmerman, G. A. (2005) Mem Inst
Oswaldo Cruz 100 Suppl 1, 83-91. Figure 2B is from Tjoelker, L. W., and Stafforini, D.
M. (2000) Biochimica Et Biophysica Acta-Molecular and Cell Biology o f Lipids 1488,
102-123

PAF is produced primarily by cells o f the hematopoietic cell lineage and common
sources o f PAF include macrophages, monocytes, neutrophils and eosinophils (6).
Though not part o f the hematopoietic cell lineage, endothelial cells are also able to
produce PAF (2). In cells producing PAF, the primary means o f synthesis is through the
enzymatic remodeling pathway shown in Figure 3 (1). A de novo pathway for PAF
synthesis exists; however, this pathway is less biologically relevant. The enzymatic
synthesis o f PAF is highly regulated and involves a two step mechanism— where the
initial step involves the remodeling o f choline containing membrane phospholipids. In
response to inflammatory challenge, cytosolic phospholipase A: (cPLAi) associates with
the cell membrane and hydrolyzes the esterified fatty acyl moiety at the sn-2 position
forming lyso-PAF. Lyso-PAF becomes acetylated by an acetyltransferase to produce
bioactive PAF. PAF then signals through its G-protein coupled receptor on various cells
of the hematopoietic cell lineage. PAF receptor activation stimulates numerous complex
signaling pathways that culminate in producing PAF’s diverse biological actions. O f
note, PAF receptor activation results in the activation o f cytosolic phospholipase A 2 and
the generation of lyso-PAF. A cycle of PAF producing PAF receptor activation and more
PAF synthesis is established. In many o f the cells that produce PAF, the fatty acid that is
esterified at the sn-2 position of membrane phospholipids is arachidonic acid (7).
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Figure 3; Enzymatic Remodeling Pathway in PAF Synthesis. The enzymatic
remodeling pathway is the primary means by which PAF is synthesized. The sn-2
position o f choline containing membrane phospholipids is esterified by a cytoplasmic
phospholipase A2 upon exposure to an inflammatory stimulus. The action o f the
cytoplasmic phospholipase A2 generates lyso-PAF. After the formation o f lyso-PAF,
PAF acetyltransferase transfers an acetate group to the sn-2 position generating bioactive
PAF. From: McManus, L. M., and Pinckard, R. N. (2000) Critical Reviews in Oral
Biology & Medicine 11, 240-258

As shown in Figure 4, arachidonic acid is the precursor for formation o f the eicosanoids
(8). Because o f this, the formation o f various eicosanoids such as thromboxanes and
leukotrienes is often concomitant with the synthesis o f PAF. These lipids, working
together, can augment the inflammatory response (1). In addition to the inflammatory
response elicited by PAF, PAF-like phospholipids are also able to induce an
inflammatory response. These PAF-like phospholipids are not derived enzymatically, but
rather result from the oxidative fragmentation o f membrane phospholipids. Unlike the

enzymatically derived PAF, whose synthesis is tightly regulated, the synthesis o f these
PAF-like phospholipids is not regulated (9) (10). Thus, a significant means to regulate
the inflammatory response elicited by both PAF and PAF-like phospholipids is through
the action o f a family o f enzymes known as PAF acetylhydrolases (PAF-AH).
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Figure 4: . Synthesis of Various Eicosanoids via Arachidonic Acid. Often, during the
enzymatic synthesis of PAF, the fatty acid moiety that is esterified at the sn-2 position is
arachidonic acid. This is o f relevance because arachidonic acid is the precursor to various
eicosanoids such as thromboxanes, prostaglandins and leukotrienes which can, in turn,
augment the inflammatory response. From; Kantarci, A., and Van Dyke, T. E. (2003) Crit
Rev Oral Biol M ed 14, 4-12

The various PAF acetylhydrolases are calcium-independent phospholipase Ass
which catalyze the removal o f the sn-1 acetate moiety, or variations at this position from
PAF or PAF-like phospholipids. Such variations, as shown in Figure 2, may consist of
oxidized functionalities derived from fragmentation of the long acyl chain o f membrane
phospholipids. The PAF acetylhydrolases convert the bioactive PAF to its biologically

inactive form lyso-PAF— thereby providing a means to interrupt the progression o f an
inflammatory response. There are two categories o f PAF acetylhydrolases: intracellular
and secreted (11). The intracellular PAF acetylhydrolases are able to recognize a diverse
array o f PAF-like phospholipids and are found in various subcelluar locations.
Additionally, the intracellular PAF acetylhydrolase has a wide range o f structures and can
be either monomeric, dimeric or heterotrimeric (2). There are three subcategories of the
intracellular PAF acetylhydrolases which include PAF acetylhydrolase Ib, PAF
acetylhydrolase II and the erythrocyte PAF acetylhydrolase. The PAF acetylhydrolase Ib
is thought to control PAF levels in the brain and mutations in the P-subunit o f this
enzyme cause Miller-Dieker lissencephaly (12). PAF acetylhydrolase II is a 40 kDa
protein found in various tissues and has similar function to the plasma form o f the
enzyme— the main difference being a substrate preference for short acyl groups at the sn2 position (13). The primary function o f PAF acetylhydrolase II is the protection from
damage induced by lipid oxidation (14). The erythrocyte PAF acetylhydrolase is
composed o f two identical 25 kDa subunits (15). The function o f the erythrocyte PAF
acetylhydrolase is intriguing because erythrocytes do not produce nor are they stimulated
by PAF. Possibly, the erythrocyte PAF acetylhydrolase hydrolyzes oxidatively
fragmented phospholipids which are usually formed in high oxygen situations or as
byproducts o f free radical reactions (16). Though the intracellular PAF acetylhydrolases
are diverse and important in function, the primary focus o f this research concerns the
action o f the plasma PAF acetylhydrolase.
The plasma

form o f PAF

acetylhydrolase

(referred to

solely

as PAF

acetylhydrolase in subsequent use, unless otherwise noted) was isolated in 1985 by Farr

et al. and the cDNA was subsequently cloned in 1995 by Tjoelker et al. (17,18). The
difficulty in purification of PAF acetylhydrolase was due to its association with LDL
particles in the serum. Two-thirds o f the PAF acetylhydrolase in serum is associated with
LDL and the remaining one-third with HDL (19-21). The first seventeen residues o f the
protein encoded by the cDNA are hydrophobic and most likely direct the enzyme for
secretion. The subsequent twenty-four residues are not found in the mature PAF
acetylhydrolase and may represent a pre-pro-peptide. Additionally, the primary structure
of PAF acetylhydrolase contains a GXSXG m otif which is homologous to many lipases
and serine esterases (22,23). The active sites o f many serine esterases contain a serine,
aspartate and histidine triad; a similar triad is found in the active site o f PAF
acetylhydrolase— indicating that the active site o f both PAF acetylhydrolase and serine
esterases may be similar.
Increases in PAF acetylhydrolase activity have been implicated in many disease
states such as vascular disease, ischemic stroke and diabetes mellitus (24,25). Within the
human population, the level o f activity o f PAF acetylhydrolase varies five-fold— 60% of
this variation is attributed to genetic factors where some o f this variability can be
attributed to varying levels of LDL-cholesterol (26,27). Because changes in activity of
PAF acetylhydrolase may be linked to certain disease states, it is important to investigate
whether PAF acetylhydrolase levels can be an indicator o f disease— especially those with
an inflammatory component. Numerous studies have shown strong correlations between
PAF acetylhydrolase activity and LDL-cholesterol levels— with higher LDL-cholesterol
levels accompanied by higher PAF acetylhydrolase levels. This is supported by patients
with hypercholesterolemia treated with a HMG-CoA reductase inhibitor showing

decreased plasma PAF acetylhydrolase activity in conjunction with lower LDLcholesterol levels (26,28). Individuals suffering from systemic lupus erythematosus also
show decreased PAF acetylhydrolase levels alongside reduced LDL levels (29). Further,
patients with lower pre-operative PAF acetylhydrolase enzyme levels were more prone to
developing systemic inflammatory response syndrome after cardiac surgery as compared
to patients with normal circulating PAF acetylhydrolase enzyme levels (30). Because the
association of PAF acetylhydrolase activity and disease appears well correlated, it is
important to investigate the ability of various proinflammatory mediators to regulate the
expression o f PAF acetylhydrolase and investigate the cellular pathways involved in such
regulation. This research will aid in developing a clearer picture o f the physiologic role
played by this anti-inflammatory enzyme.
Lipopolysaccharide (LPS) is a component o f the cell wall o f gram negative
bacteria and all o f the pathophysiological responses consequent to bacterial sepsis can be
attributed to LPS. Further, purified LPS is utilized in the laboratory as a potent stimulator
o f the inflammatory response to investigate specific cellular and biochemical processes.
Recognition o f LPS is accomplished through a complex interaction o f cell-surface
receptors and co-receptors. (Figure 5). Briefly, LPS will interact with the LPS binding
protein (LBP) and activate toll like receptor 4 (TLR-4) via CD 14— thus, initiating
activation o f the intracellular MAPK cascades (31). (See Figure 5). Work by Howard et
al. demonstrated the in vivo upregulation o f PAF acetylhydrolase mRNA levels in
response to LPS challenge in rats. Specifically, the increased expression o f PAF
acetylhydrolase was detected in Kupffer cells, the resident macrophages o f the liver (32).
Further, previous literature has shown that in THP-1/CD14 cells, a human monocyte-like
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Figure 5: LPS Signaling via MAPK Pathway. Upon exposure to lipopolysaccharide
(LPS) in serum, LPS will interact with the lipopolysaccharide binding protein (LBP).
This new LPS-LBP complex is delivered to a cell surface receptor called CD 14. CD 14
then delivers LPS to a member o f the toll-like receptor super family called toll like
receptor 4 (TLR4). LPS binding to TLR4 activates the various portions o f the MAPK
cascades and the transcription o f various genes. Adapted from;
Guha, M., et al. Cellular Signaling 13 (2001) 85-94.

cell line that over expresses CD 14, the LPS-induced upregulation o f PAF acetylhydrolase
is solely p38MAPK dependent (33). In contrast, other researchers have documented that
in cultured macrophages there is a decrease in PAF acetylhydrolase expression upon
exposure to LPS (32,34). This observation may be related to the activation o f these
macrophages in vitro and adherence to the cell culture vessel. Because TNF-a and PAF
are known pro-inflammatory mediators and activators o f macrophages, an investigation
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o f their ability to upregulate PAF acetylhydrolase mRNA levels was deemed pertinent.
PAF, as discussed above, is a potent pro-inflammatory phospholipid whose signaling is
mediated by the seven membrane spanning G-protein coupled receptor. Additionally,
TNF-a, a cytokine, primarily produced by macrophages, is involved in acute systemic
inflammation (35).
In order to investigate the mechanism of increased PAF acetylhydrolase
expression in response to inflammatory mediators, monocyte-macrophage 6 cells (MM6)
were used because initial experiments demonstrated the MM6 cells increased PAF
acetylhydrolase expression in response to LPS exposure (36)— a result identical to that
detected in macrophages in vivo. This physiologically relevant cell line spans the
monocyte macrophage differentiation lineage, is derived from a human leukemia patient,
and grows in suspension. The latter fact is important because adherent macrophage cell
lines, such as the RAW264.7 cell line, demonstrate opposite effects o f LPS-induced PAF
acetylhydrolase induction with respect to the response observed in vivo (i.e. LPS
decreases PAF acetylhydrolase expression in vivo). Monocytes/macrophages are part of
the non-specific innate immune system in which the inflammatory response is involved.
In contrast, the slower, yet more specific, adaptive immune system is antigen dependent
and does not directly involve macrophages/monocytes. However, macrophages are
antigen-presenting cells. After an invading microbe is phagocytosed by a macrophage,
the macrophage presents the peptide fragments o f the microbe on it surface via class II
MHC. Via CD4 co-receptor interaction, macrophages are able to activate helper T-cells
which, via secretion o f various interleukins, activate the antibody producing B-cells.
Thus, macrophages able to provide a link to the innate immune response via helper T-cell

11

activation. Thus, because MM6 cells represent a physiologically relevant cell culture
model, they were used in all subsequent experiments in this study.
To investigate the ability o f PAF and TNF-a to alter PAF acetylhydrolase
expression and to ascertain any similarities or differences to the LPS-induced signaling
pathways Real-Time PCRs, ELISAs, and an inducer o f reactive oxygen species, tertbutyl hydroperoxide, were all employed. In this study, we were able to demonstrate the
ability of both TNF-a and PAF to upregulate PAF acetylhydrolase expression. In
addition, we examined the various signaling pathways involved in the upregulation of
PAF acetylhydrolase mRNA and were able to gain a greater understanding o f the various
MAPK cascades involved in PAF acetylhydrolase mRNA upregulation. Further, we
demonstrated that reactive oxygen species may play a role in inducing PAF
acetylhydrolase

expression

and

that

the

LPS-induced

acetylhydrolase mRNA levels also involves the PAF receptor.
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upregulation

of

PAF

CHAPTER 2

MATERIALS AND METHODS
2.1 Materials
Monocyte-Macrophage 6 cells (A generous gift from Shamim Mustafa), Fetal Bovine
Serum (Atlanta Biological), Penicillin/Streptomycin (HyClone), Non-essential amino
acids (HyClone), RPMI Media (Cellgro), Lipopolysaccharide (Sigma), Platelet
Activating Factor (Sigma), TNF-a ( Sigma), High capacity cDNA Reaction Kit (Applied
Biosystems), 2x Universal PCR Master Mix (Applied Biosystems), TaqMan Primers
(Applied Biosystems), Live Green ROS Detection Kit (Invitrogen), All ELISA kits
(R&D Systems).

2.2

Maintenance o f the Human Monocyte-Macrophage 6 Cell Line

Human Monocyte-Macrophage 6 (MM6) cells, derived from a Leukemia patient and
grown in suspension, were obtained from Dr. Shamim Mustafa and were stored at
-180°C. Upon use, ImL o f MM6 cells were quickly thawed from deep freeze and were
resuspended in 10 mU RPMI media supplemented with the following components in their
final concentrations: 10% fetal bovine serum, 10000 U/mL Penicillin, 10000 pg/mL
Streptomycin, 1 mM oxaloacetate, 0.45 mM pyruvate, 0.2 U/ml insulin, and Ix nonessential amino acids. The MM6 cells were counted with the use o f a hemocytometer,
centrifuged and were seeded in a twenty-four well tissue culture plate at an initial density
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of 5x10^ cells/mL with 2 mL/well o f complete media and cultured overnight.
Subsequently, MM6 cells were seeded at a density of 2x10^ cell/well in twenty-four well
tissues culture plates (2 mL/well) for each subsequent passage. Cells were maintained at
37°C, in a humidified 5% CO 2 atmosphere for 2-3 days before use in any subsequent
experiments. MM6 cells were split every two days, and the cells used in all experiments
did not exceed sixteen passages.

Isolation and Quantization o f RNA

2.3

All RNA isolation procedures were based on the method outlined by Sacchi and
Chomczynski (37). MM6 cells were pelleted by centrifugation and were lysed in 1 mL
TRIzol Reagent by repetitive pipetting. Lysates were transferred to 1.5 mL eppendorf
tubes. For each 1 mL o f TRIzol Reagent, 200 pL chloroform was added to each sample
tube. Sample tubes were shaken vigorously for fifteen seconds and incubated at 15 to
30°C for 2-3 minutes. Samples were then centrifuged at 12,000xg for 15 minutes at 4°C.
The clear upper aqueous phase was transferred to a new eppendorf tube and 500 pL
isopropyl alcohol was added per ImL o f TRIzol Reagent initially used. The sample tube
was shaken vigorously for fifteen seconds and centrifuged at 12,000xg for thirty-minutes
at 4°C to pellet the RNA. The supernatant was removed and RNA pellets were washed
with 1 mL cold 75% ethanol per mL o f TRIzol Reagent initially used. Sample tubes were
then mixed vigorously by vortexing and were centrifuged at 7,500xg for 5 min at 4°C.
The supernatant was removed and the RNA pellet was allowed to air dry for fiveminutes. RNA pellets were then resuspended in 40 pL diethyl pyrocarbonate treated
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water. To quantify the isolated RNA, 3 pL o f sample was diluted in 197 pL o f Mili-Q
water in a 96-well low-UV plate. The Spectra Max Plus microplate reader was used to
obtain the optical density at 260nm and 280nm. The absorbance units at 260 nm provided
the RNA concentration and the 260/280 ratio indicated the purity o f the RNA.

2.4 Performance o f cDNA Synthesis
Five pg RNA was reverse transcribed in 60 pL cDNA reactions with use of the High
Capacity cDNA synthesis kit supplied by Applied Biosystems. Random Primers were
used to initiate the cDNA synthesis and were supplied at lOx, Multiscribe for reverse
transcription was supplied at 50 U/pL, the Reverse Transcriptase buffer was supplied as a
lOx solution and 25x dNTP buffer was supplied at a 100 mM concentration. All samples
were mixed in their appropriate concentrations to give a Ix solution. Multiscribe was
diluted to a final concentration o f 75 U/pL and the 25 dNTP buffer was prepared at a
final concentration 4 mM. Prepared samples were heated to 25°C for ten minutes and
then 37°C for two hours using the GeneAmp PCR systems 2400 machine.

2.5 Performance o f Real-Time PCR
Thirty pL Real-Time PCR reactions were performed using 5 pL o f cDNA created as
described above. TaqMan primers (20x) specific for the human PAF acetylhydrolase and
18S ribosomal RNA and Universal PCR Master Mix (2x) were obtained from Applied
Biosystems. Real-time PCRs were performed on the Applied Biosystems 7000 Real-
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Time PCR machine to amplify the PAF acetylhydrolase cDNA. To make this method
quantitative, four, five-fold serial dilutions o f cDNA was reverse transcribed from 6 pg of
RNA isolated from LPS treated MM6 cells and were run simultaneously with the
experimentally derived cDNAs. Each dilution was assigned an arbitrary numerical value
that was indicative o f a five-fold serial dilution. In this way a quantitative numerical
value is obtained where fold-induction in PAF acetylhydrolase levels over control can be
ascertained. To correct for slight differences in RNA concentration, 18S levels were
analyzed by Real-Time PCR as described above and the ratio o f PAF-AH to 18S levels
was determined. See Figure 6.

Performance o f Dose Response Experiments

2.6

MM6 cells were seeded at a density o f 2x10^ cells/mL in 2 mL o f complete media, and
were incubated in a humidified 5% CO 2 environment at 37°C for twenty-four hours prior
to the start o f any experiments. Subsequent to this, dose response experiments were
performed for PAF, in its most potent form (l-0-Hexadecyl-2-0-acetyl-sn-glycero-3phosphocholine), LPS (from E. coli, serotype: 011LB4) and TNF-a. The PAF was
prepared as a 100 mM stock solution dissolved in chloroform. Ten pL o f the stock
solution was dissolved in 990 pL anhydrous ethanol. The 1 mL solution was dried under
a N 2 gas stream. The dried PAF was then resuspended in 240 pL phosphate buffered
saline (PBS) supplemented with 1% Bovine Serum Albumin (BSA) and sonicated for
ten-minutes before use in any experiments.

A 2 mg/mL stock solution o f LPS was

dissolved in IxPBS. Before use in experiments, 10 pL o f the 2 mg/mL stock was
dissolved in 90 pL IxPBS.
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A. PAF-AH Standard Curve
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Figure 6: Real-Time PCR PAF-AH and 18S Standard Curves. A. FAF
acetylhydrolase standards were prepared by reverse transcribing 6 pg o f RNA to cDNA.
Using the cDNA, four, five-fold serial dilutions were used to generate each standard. The
undiluted standard was given an arbitrary value o f 500 units. Each subsequent dilution
was given a value indicative o f a five fold serial dilution. B. 18s standards were generated
by reverse transcribing 6 pg o f RNA to cDNA. An initial 1:100 dilution was made o f the
cDNA. From this, a series o f four, five-fold serial dilutions were generated and assigned
values in the same manner as described in part A. above.
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A 25 mM stock solution o f TNF-a was prepared dissolved in IxPBS. PAF was
administered to MM6 cells at concentration o f 0 pM, 0.125 pM, 0.25 pM and 0.5 pM.
LPS was administered at concentration o f 0 ng/mL, 50 ng/mL, 100 ng/mL and 200
ng/mL. TNF-a was administered at concentrations o f 0 ng/mL, 5 ng/mL, 10 ng/mL and
20 ng/mL. At twenty-four hours after administration, the cells were harvested by
centrifugation and RNA was isolated, reverse transcribed to cDNA and Real-Time PCR
experiments were performed.

Performance o f Seventy-two Hour Time Course Experiments

2.7

MM6 cells were seeded at a density o f 2xl0^cells/mL in 2 mL o f complete media,
cultured for twenty-four hours and were then treated with either 200 ng/mL LPS, 10
ng/mL TNF-a or 0.5 pM PAF. In each experimental condition cells were incubated with
either o f the aforementioned pro-inflammatory mediators for 0, 1,3, 6, 12, 24, 48, and 72
hours. For LPS treated cells, seventy-two hour time course experiments were also run in
the absence o f 10% FBS by washing copiously with IxPBS and resuspending in RPMl
lacking serum. MM6 cells were also incubated for seventy-two hours in the absence of
LPS for both serum containing and serum free RPML After each time point, RNA was
isolated, reverse transcribed to cDNA and analyzed in real-time PCR experiments as
described above.

2.8

Performance o f Synergistic PAF-AH Induction

MM6 cells were seeded at a density o f 2x10^ cells/mL in 2 mL o f complete media,
cultured for twenty-four hours and were then treated with either 200 ng/mL LPS, 10
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ng/mL TNF-a or 0.5 pM PAF. In addition, various combinations o f the aforementioned
mediators were dually administered in each well. MM6 cells were cultured for twentyfour hours and RNA was isolated, reverse transcribed to cDNA and analyzed in RealTime PCR experiments.

Performance o f M APK inhibition experiments

2.9

MM6 cells were seeded at a density o f 2xl0^cells/mL in 2mL o f complete media,
cultured for twenty-four hours and were then treated with either 15pM SB203580
(p38MAPK inhibitor) or 15pM PD980058 (ERR 1/2 inhibitor) one hour prior to addition
o f either 200 ng/mL LPS, 0.5 pM PAF, or 10 ng/mL TNF-a. Cells were then harvested
twenty-four hours later and RNA was isolated, reverse transcribed to cDNA and analyzed
by real-time PCR experiments as described above.

2 .\0 Preparation o f MM 6 cells fo r ELIS As
MM6 cells were plated in serum-containing RPMl media for twenty-four hours as
described above. MM6 cells were then switched into serum free media, after multiple
wash steps with Ix PBS, and seeded at density o f 4x10^ cells/mL and allowed to incubate
overnight. Five-hundred ng/mL LPS were administered and MM6 cells were incubated
for twenty-four hours. Cells were harvested at various time points and centrifuged.
Conditioned media were collected and stored at -20°C. Cell pellets were lysed with lysis
buffer containing phosphatase inhibitors and preservatives supplied by R&D Systems.
Cells lysates were then supplemented with protease inhibitor cocktail from Sigma before
use in subsequent experiments.
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2.11 Performance o f ELISA fo r IL-1^
ELISA kits were obtained from R&D Systems. The Quantikine Human IL -ip /1L-1F2 kit
was used to assay for IL -ip. All supplied reagents were prepared according to the
manufacturers instructions. Two-hundred pL of standard, sample or control were applied
to antibody coated wells supplied by the manufacturer and allowed to incubate for two
hours at room temperature. Wells were then aspirated and washed three times with wash
buffer containing surfactant and preservatives four times. Two-hundred pL o f a
polyclonal antibody against IL -ip conjugated to horseradish peroxidase was then loaded
into each well and incubated for one hour. Again, wells were aspirated and washed three
times. A two-hundred pL mixture of stabilized horseradish peroxidase and chromogen
(trimethylbenzidine) were then added to each well and incubated, protected from light,
for twenty-minutes. Fifty pL o f a 2N sulfuric acid stop solution was added to each well
and the absorbance determined at 450 nm with wavelength correction at 540 nm within
thirty-minutes of addition of the stop solution. A standard curve was generated using a
four parameter logistic curve fit.

2.12 Performance o f ELISA fo r TNF-a
ELISA kits were obtained from R&D Systems. The Quantikine Human TNF-a /SFIA kit
was used to assay for TNF-a. All supplied reagents were prepared according to the
manufacturers instructions. Fifty pL o f the provided Assay Diluent R D IF was added to
each antibody coated well. 200 pL o f standard, control or sample were added to each well
and allowed to incubate for two hours. Wells were then aspirated and washed with wash
buffer containing surfactant and preservatives four times. Two-hundred pL o f a
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polyclonal antibody against TNF- a conjugate to horseradish peroxidase was added to
each well and incubated for one hour. Wells were then aspirated and washed four times.
A 200 pL mixture o f stabilized hydrogen peroxide and chromogen (trimethylbenzidine)
was then added to each well and incubated, protected from light, for twenty-minutes.
Fifty pL o f 2N sulfuric acid stop solution was added to each well and absorbance
determined at 450 nm with wavelength correction at 540 nm within thirty-minutes. A
standard curve was created using a four parameter logistic curve fit.

Performance o f ELISA fo r Phospho-p38a

2.13

ELISA kits were obtained from R&D Systems. The Surveyor 1C kit was used to assay for
Phospho-p38a. All supplied reagents were prepared according to the manufacturers
instructions. One-hundred pL o f standard, sample or control were added to each antibody
coated well and incubated for two hours. Wells were then aspirated and washed with
wash buffer containing surfactant and preservatives four times. One-hundred pL of
strepavidin-horseradish peroxidase was added to each well and incubated for twentyminutes. A

100 pL mixture of stabilized hydrogen peroxide

and chromogen

(trimethylbenzidine) was then added to each well and incubated, protected from light, for
twenty-minutes. Fifty pL o f stop solution was added to each well and absorbance
determined at 450nm with wavelength correction at 540nm within thirty-minutes. A
standard curve was fit using a four parameter logistic curve fit.
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2.14

Performance o f PAF Receptor Antagonist Experiments

MM6 cells were cultured in serum-containing media at a density o f 2x10^ cells/mL and
used in experiments twenty-four hours later. The PAF receptor antagonist, WEB2170
was a generous gift provided by Merle S. Olson, University o f Texas Health Sciences
center. The p38MAPK inhibitor, SB203580, and the PAF receptor antagonist, WEB2170,
were administered either one-hour or fifteen-minutes prior to administration o f LPS or
PAF respectively. In instances where W EB2I70 and SB203580 were administered
dually, W EB2I70 and SB203580 were administered immediately together followed by
LPS and PAF administration one hour later. Cells were harvested at twenty-four hours
and RNA was isolated based on the method outlined by Sacchi and Chomczynski. Five
pg of RNA, for each experimental condition, were reverse transcribed to cDNA and were
used in Real-Time PCR reactions as described above.

2.15

Performance o f Reactive Oxygen Species Induction

MM6 cells were cultured in serum-containing media at the appropriate density as
described above. Two pL of a 100 mM tert- butyl hydroperoxide (TBHP) stock solution
was administered to MM6 cells in the 2 mL cell culture plates, in complete media, to
produce a final concentration o f 100 pM TBHP on the cells. Cells were harvested at 0, 1,
3, 6, 12 and 24 hours and RNA was isolated as described above. Five pg o f RNA, for
each experimental condition, were reverse transcribed to cDNA and were used in RealTime PCR reactions.
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Identifying Morphological Changes in MM6 Cells

2.16

Various combinations of 0.5 pM PAF, 200 ng/mL LPS and 10 ng/mL TNF- a were
administered to MM6 cells in serum-containing media. Twenty-four hours later, pictures
o f the MM6 cells were taken through use a digital camera attached to a Zeiss Axiovert
inverted microscope (Gottingen, Germany). Pictures were taken at a total magnification
of50X .

2.17 Performance o f Statistical Analysis
T-tests

were

conducted

to

determine

if

there

were

significant

differences

between selected variables (i.e. varying doses o f LPS treatment vs. control) where
comparisons were made between one control group and one treatment group. Analysis of
variance (ANCVA) were conducted to determine if there were significant differences
between selected variables (i.e. PAF-AH mRNA fold-induction over control in the
presence o f various inhibitors and inflammatory mediators ) where comparisons were
made between a control group and more than one treatment group. Repeated measures
were conducted between selected variables (i.e. seventy-two hour time course
experiments in the presence o f various inflammatory mediators) where comparisons were
made between one control group and one treatment group across several time periods. All
analyses were conducted using SPSS 16.0 (SPSS, Inc., Chicago, IL).
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CHAPTER 3

RESULTS
The goal o f this research is to investigate whether TNF-a and PAF are able to upregulate
PAF acetylhydrolase expression and, to ascertain any similarities or differences in
signaling to that detected with LPS. Cultured MM6 cells were used in experiments for
their ability to induce PAF acetylhydrolase expression in response to LPS in vitro—
similar to the response demonstrated in vivo.

Dose Response o f Various Pro-inflammatory Mediators

3.1

In order to determine if LPS, PAF and TNF-a are able to upregulate PAF acetylhydrolase
expression,

dose response experiments, measuring

the fold induction o f PAF

acetylhydrolase mRNA, were performed. See Figures 7-9. MM6 cells were cultured in
serum-containing

media

for twenty-four hours prior to

administration

o f the

proinflammatory mediators. After a twenty-four hour inflammatory challenge with the
aforementioned mediators, PAF acetylhydrolase mRNA levels were ascertained through
Real-Time PCR. For all doses o f LPS, a 15-20 fold induction o f PAF acetylhydrolase
mRNA was observed over control levels as shown in Figure 7. One-hundred ng/mL LPS
produced a maximal 20-fold induction in PAF acetylhydrolase levels over control. At 200
ng/mL LPS, PAF acetylhydrolase mRNA levels decreased slightly from the maximal
values but still resulted in a sixteen-fold induction over control levels. For all o f the
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concentrations o f PAF, a 3.5-4.5 fold induction o f PAF acetylhydrolase message was
observed. (See Figure 8). However, the upregulation o f PAF acetylhydrolase levels did
not appear to be dose-dependent— though, some variability was detected. The TNF-a
induced PAF

acetylhydrolase levels showed a 6.5-10 fold induction o f PAF

acetylhydrolase message over control for all concentrations o f TNF-a administered. As
shown in Figure 9, incremental increases in PAF acetylhydrolase mRNA were observed
for increasing concentrations o f TNF-a. Administration o f 20 ng/mL TNF-a resulted in
the largest increase in PAF acetylhydrolase (10-fold) however, higher concentrations
were not tested.
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Figure 7: LPS Dose Response. MM6 cells were cultured in serum-containing media for
twenty-four hours. Incremental increases in PAF-AH mRNA levels are observed up 100
ng/mL LPS administration. At 200 ng/mL LPS administration, MM6 cells appear to
become desensitized to the increase LPS administration. The data reflect a value o f two
independent biological samples analyzed in triplicate; mean difference is significant at
p<0.05. The single asterisk represents statistical significance from all other values. Error
bars represented are +/- standard deviation.
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Figure 8: PA F Dose Response. MM6 cells were cultured in serum-containing media for
twenty-four hours in the presence o f various concentrations o f PAF. The PAF induced
PAF-AH mRNA levels do not appear to be dose dependent. This is observation is most
likely due to the presence of PAF-AH in the 10% FBS. Fold-induction o f PAF-AH levels
is statistically different than control for all concentrations o f PAF administered. The data
reflect a value o f two independent biological samples analyzed in triplicate; mean
difference is significant at p<0.05. Single asterisk represents statistical difference
between 0.25pM PAF and 0.5pM PAF. Error bars represented are +/- standard deviation.
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Figure 9: TNF-a Dose Response. MM6 cells were cultured in serum-containing media
for twenty-four hours. The TNF-a induced upregulation o f PAF acetylhydrolase shows
increased expression of PAF acetylhydrolase with incremental increase in TNF-a dosage.
The data reflect a value o f two independent biological samples analyzed in triplicate;
mean difference is significant at p<0.05. The single asterisk represents statistical
significance from the control. Error bars represented are +/- standard deviation.

3.2

Lipopolysaccharide Induced Expression o f PAF-AH mRNA in MM 6 Cells

LPS is a component o f the cell wall o f gram-negative bacteria and is known to elicit proinflammatory responses that result in the upregulation o f PAF Acetylhydrolase levels in
vivo. In order to characterize the extent and time frame o f the LPS induced PAF
acetylhydrolase response, MM6 cells were cultured with 200 ng/mL LPS over a seventytwo hour period in either serum-containing or serum-free RPMl media. See Figures 10
and 11. Time course experiments for MM6 cells cultured in serum-containing media
showed control levels o f PAF Acetylhydrolase mRNA levels after one hour o f LPS
treatment. Subsequent to this, PAF Acetylhydrolase mRNA levels rose steadily—
reaching a maximal 8-fold induction, compared to control levels, at twenty-four hours. At
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forty-eight and seventy-two hours, PAF acetylhydrolase mRNA levels slightly decreased
to a level that was approximately six-fold above control levels. Control cells, not
receiving any LPS treatment, were incubated for the entire time course. Near control
levels o f PAF acetylhydrolase were detected in all samples.
In order to determine the importance o f the lipopolysaccharide binding protein
(LBP) in mediating the effects o f LPS with respect to PAF Acetylhydrolase mRNA
upregulation, MM6 cells were cultured in serum-free media with either 200 ng/mL LPS
or in the absence o f LPS for seventy-two hours as shown in Figure 11. In the absence o f
serum, PAF acetylhydrolase mRNA levels were similar to levels detected after exposure
to 200 ng/mL LPS in serum-containing media for the initial twenty-four hours.
Subsequent to this time, an approximately thirty and sixty fold increase in PAF
acetylhydrolase mRNA levels was detected at forty-eighty and seventy two hours
respectively in both MM6 cells cultured in serum-free media in the presence or absence
o f LPS.
3.3 Platelet Activating Factor Induced Expression o f PAF- A H mRNA in MM6 Cells
PAF is a known potent phospholipid aetivator and mediator o f many leukoeyte
funetions, ineluding platelet aggregation, inflammation, anaphylaxis and has been shown
to be a eentral mediator in indueing an inflammatory response (38). The enzyme PAF
aeetylhydrolase,

a ealeium-independent phospholipase A 2 , eonverts PAF to its

biologieally inaetive form, lyso-PAF. This relationship between PAF and PAF
aeetylhydrolase suggests that the presenee o f PAF may upregulate PAF aeetylhydrolase
expression. To investigate the extent, if any, by whieh PAF is able to upregulate PAF
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acetylhydrolase mRNA levels, MM6 cells were cultured for seventy-two hours in serumcontaining RPM l media in the presence o f 0.5 pM PAF. (See Figure 12). Near control

Time Course of LPS-lnduced Induction of PAF-AH in Presence
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Figure 10: Serum-Containing Seventy-two Hour Time Course. MM6 cells were
cultured for seventy-two hours in serum-containing RPMl media in the presence o f either
200 ng/mL LPS or 0 ng/mL LPS. For MM6 cells incubated in the presence of serum,
maximal fold induction o f PAF acetylhydrolase levels occur at twenty-four hours. Levels
drop by forty-eight hours and a slight increase in PAF acetylhydrolase induction is
observed at seventy-two hours. MM6 cells cultured in absence o f LPS show near control
levels of PAF acetylhydrolase induction. The data reflect a value o f two independent
biological samples analyzed in triplicate; mean difference is significant at p<0.05. The
single asterisks represent statistical significance from control. Error bars represented are
+/- standard deviation.

levels o f PAF acetylhydrolase mRNA expression were observed within six hours o f 0.5
pM PAF exposure. PAF Acetylhydrolase mRNA levels increase five-fold over control
levels at twelve hours of 0.5 pM PAF exposure. PAF acetylhydrolase levels fall to eight
fold over control by seventy-two hours.
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Fold PAF-AH Induction in Serum Free RPMl for MM6 Cells
100 n
90
CO
00

80 70

1

60

<

50
40

■-S

30
20

0.
o
GC

DD200 ng/mL LPS
■ 0 ng/mL LPS

10
0
Ohr

1hr

3hr

6hr

12hr

24hr

48hr

72hr

Figure 11; Serum-Free Seventy-two Hour Time Course. MM6 cells incubated in
serum free RPMl with either 200 ng/mL LPS or 0 ng/mL LPS over a seventy-two hour
time course. Fold induction o f PAF acetylhydrolase between the two experimental
conditions show no statistical difference. The data reflect a value o f four independent
biological samples analyzed in triplicate for LPS-induced cells; The data reflect a value
o f two independent biological samples analyzed in triplicate for control cells. There was
no statistical difference between control and experimental conditions. Error bars
represented are +/- standard deviation.

3.4

Tumor Necrosis Factor- a Induced Expression o f PAF-AH mRNA in MM 6 Cells

TNF-a is a 17 kDa cytokine involved in acute phase systemic inflammation. TNF-a is
mainly produced by macrophages, but also by a broad variety o f other cell types
including lymphoid cells, mast cells, and endothelial cells. Large amounts o f TNF-a are
released in response to lipopolysaccharide, other bacterial products, and interleukin-1
(39) (35). To investigate the extent and time frame by which TNF-a is able to upregulate
PAF acetylhydrolase mRNA levels in MM6 cells, cells were cultured for seventy-two
hours in the presence o f 10 ng/mL TNF-a in serum-containing media.
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Figure 12: PAF Induced Serum-Containing Seventy-two Hour Time Course. MM6
were cultured in serum containing RPM l media for seventy-two hours in the presence o f
0.5 pM PAF. Levels of PAF acetylhydrolase induction remain relatively steady upon until
12 hours o f PAF exposure. The data reflect a value o f two independent biological
samples analyzed in triplicate; mean difference is significant at p<0.05. Single asterisk
represents statistical difference from the control. Error bars represented are +/- standard
deviation.

As shown in Figure 13, levels o f PAF acetylhydrolase mRNA remained steady, near
control levels, up until six hours o f exposure to TNF-a— where a two-fold induction,
above control levels, was observed. PAF acetylhydrolase levels increased nine-fold,
above control levels, at twenty-four hours o f TNF-a exposure and abruptly returned to
control levels by seventy-two hours.
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Figure 13: TNF-a Serum-Containing Seventy-two Hour Time Course. MM6 cells
were cultured in serum-containing RPMl media for seventy-two hours in the presence of
10 ng/mL TNF-a. Levels of PAF acetylhydrolase induction begin to rise by three hours
and reach maximal levels of induction by twenty-four hours. PAF acetylhydrolase levels
then drop abruptly by seventy-two hours. The data reflect a value o f two independent
biological samples analyzed in triplicate; mean difference is significant at p<0.05. Single
asterisk represents statistical difference from the control. Error bars represented are 4-/standard deviation.

3.5 PAF-AH mRNA Induction in Response to Dually Administered Pro-Inflammatory
Mediators
Recent work by Stafforini et al. has shown that LPS-induced PAF Acetylhydrolase
upregulation is mediated entirely through p38MAPK in the monocyte-like cell line, THP1/CD14 (40). In order to determine if PAF, TNF-a, and LPS can augment function in a
synergistic manner, combinations of dually administered pro-inflammatory mediators
were added to a MM6 cell culture and the levels o f PAF acetylhydrolase mRNA were
determined. Administration o f either 200 ng/mL LPS, 10 ng/mL TNF-a, or 0.5pM PAF
showed a 15, 12 and 4.5-fold induction over control PAF acetylhydrolase mRNA levels,
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respectively. The effects o f the dually administered pro-inflammatory mediators are
shown in Figure 14.
Dual Administration of Proinflammatory MediatorsI

60
50
I

40

I

**

* * *

.2

% 20

O'

10

Control

i ■
LPS

TNF-a

PAF

LPS + TNF-a

TNF-a + PAF

LPS + PAF

Figure 14: Dual Administration of Proinflammatory Mediators. MM6 cells were
cultured in serum containing RPMl media and were incubated with various combinations
of proinflammatory mediators. Strong fold induction o f PAF acetylhydrolase mRNA
levels were observed with LPS and TNF-a administered in combination and near additive
effects in PAF acetylhydrolase induction were observed for TNF-a + PAF and LPS +
PAF. The data reflect a value o f two independent biological samples analyzed in
triplicate; mean difference is significant at p<0.05. The single asterisk represents
statistical difference from LPS-induced cells. The double asterisk represents statistical
difference from TNF-a induced cells. The triple asterisk represents statistical difference
from PAF-induced cells. Error bars represented are +/- standard deviation.

The combination o f LPS and TNF-a showed a marked increase o f forty-five fold
induction over control levels at twenty-four hours. TNF-a + PAF and LPS + PAF showed
a more modest synergistic twenty-five and twenty-two fold increase in PAF
acetylhydrolase levels over control respectively. These latter results showed a near
additive effect in PAF acetylhydrolase mRNA upregulation.
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3.6

Determination o f Essential M APK Signaling Pathways fo r LPS, PAF and TNF-a

LPS is able to induce proinflammatory responses via activation o f numerous intracellular
signaling pathways. A recent review article summarized the major pathways activated by
LPS. These pathways include the MAPK cascades— ER K l/2, JNK, and p38— as well as
the NFkp/Ikp intracellular signaling pathway (31). (See Figure 5). In order to investigate
if the MAPK pathways are essential for upregulation o f PAF acetylhydrolase, and
whether PAF and TNF-a also signal through similar mechanisms, use o f various MAPK
inhibitors were employed. The inhibitors, PD98059 and SB203580 were used to inhibit
the ER K l/2 and p38MAPK portions o f the MAPK pathway respectively as shown in
Figures 15-17. MM6 cells were cultured in serum-containing media and were
administered the inhibitors one-hour prior to administration o f the proinflammatory
agonist. Use o f 15 pM SB203580 showed an approximately 50% decrease in PAF
acetylhydrolase levels compared to MM6 cells treated with 200 ng/mL LPS alone as
depicted Figure

15. A more modest 20% decrease in TNF-a mediated PAF

Acetylhydrolase levels was observed with the inhibitor as compared to cells treated with
10 ng/mL TNF-a alone. (Figure 15). Administration o f SB203580 also decreased the
PAF-induced PAF

acetylhydrolase

levels

by

approximately 20%.

(Figure

17).

Paradoxically, inhibition o f the ER K l/2 portion o f the MAPK pathway with 15 pM
PD98059 increased PAF acetylhydrolase expression by 50% relative to administration of
the pro-inflammatory mediators alone for LPS, PAF and TNF-a. (Figures 16 and 17).
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Fold Induction of PAF-AH Upon Exposure to the p38MAPK inhibitor, SB203580
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Figure 15: Inhibition of p38MAPK signaling via SB203580. MM6 cells treated with
either 200 ng/mL LPS or 10 ng/mL TNF-a were cultured in serum-containing RPMl
media for twenty four hours in the presence o f the pBSMAPK inhibitor, SB203580 at
15pM. A 50% decrease in LPS induced PAF-AH mRNA levels is observed in the
presence o f SB203580. An approximately 20% decrease in the PAF induced PAF-AH
mRNA levels is observed in the presence o f SB203580. Fold-induction o f PAF-AH
mRNA levels is statistically significant from control and SB203580 for all other
experimental conditions. The data reflect a value o f two independent biological samples
analyzed in triplicate; mean difference is significant at p<0.05. The single asterisk
represents a statistical difference between LPS and LPS + SB203580 treated cells. Error
bars represented are +/- standard deviation.

35

Fold Induction of PAF-AH upon exposure to the ERK1/2
Inhibitor, PD98059
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Figure 16: Inhibition of E R K l/2 Signaling via PD98059. MM6 cells, cultured in
serum-containing media for twenty-four hours show a 50% increase in PAF-AH mRNA
levels (with respect to the inflammatory mediator administered) upon administration of
the ER K l/2 inhibitor PD98058 at 15 pM. LPS was administered at a concentration 200
ng/mL and TNF-a was administered at a concentration o f 10 ng/mL. This result is most
likely due to the stress imposed on the cell after inhibition o f such a crucial pathway. See
text. All experimental conditions are statistically different than control and PD98059
administration. The data reflect a value o f two independent biological samples analyzed
in triplicate; mean difference is significant at p<0.05. The single asterisk represents
statistical difference between LPS and LPS + PD98059 treated cells. The double asterisk
represents statistical difference between TNF-a and TNF-a + PD98059 treated cells.
Error bars represented are +/- standard deviation.
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Fold Induction of PAF-AH Upon Exposure to SB203580 and
PD98059
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Figure 17: Inhibition of p38MAPK and ER K l/2 Signaling via SB203580 and
PD98059 Respectively. A.MM6 cells cultured in serum containing RPMl media were
exposed to 15 pM SB203580 and 15 pM PD98059. The PAF induced PAF
acetylhydrolase mRNA upregulation was decreased by approximately 20% in the
presence o f the p38 MAPK inhibitor. Paradoxically, inhibition o f the ER K l/2 portion of
the MAPK pathway caused an approximately 50% increase in fold induction o f PAF
acetylhydrolase levels over the induction elicited by PAF alone. PAF was administered at
a concentration o f 0.5 pM. The data reflect a value o f two independent biological
samples analyzed in triplicate; mean difference is significant at p<0.05. The single
asterisk represents a statistical difference between PAF and PAF + PD98059 treated cells.
Error bars represented are +/- standard deviation.

3.7 PAF- A H mRNA induction in Response to Dual Administration o f SB203580 and
WEB2170
Recent work by Howard et al. suggested that 50% o f the LPS-induced PAF
acetylhydrolase response in rats is due to increased signaling through the PAF receptor as
a result of increased PAF production due to LPS challenge (32). Further, our work
showed only a 50% inhibition o f the LPS-induced PAF acetylhydrolase mRNA
upregulation upon administration o f SB203580. In order to investigate if increased PAF
signaling through its receptor contributes to the upregulation o f PAF acetylhydrolase.
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MM6 cells were either singly or dually administered WEB2170 (50 pM) and SB203580
(15 pM) prior to stimulation with PAF or LPS in serum-containing media for twenty-four
hours. Figure 18 showed WEB2170 as an effective PAF receptor antagonist and inhibited
the PAF-induced increase in PAF acetylhydrolase. Both LPS and PAF, alone, showed the
typical fold induction o f PAF acetylhydrolase levels over control. As seen previously, a
50% decrease in the LPS-induced PAF acetylhydrolase mRNA, upon administration of
SB203580, was observed. Administration o f WEB2170, inhibited the LPS-induced
increase in PAF acetylhydrolase resulting in a two-fold induction over control levels.
Dual administration o f both SB203580 and WEB2170, completely abolished the LPSinduced PAF acetylhydrolase levels and depressed PAF acetylhydrolase mRNA to half o f
that detected in control cells.
3.8

ZL-7P Induction in Response to LPS Treatment

IL -ip, primarily produced by both monocytes and macrophages, is a known cytokine that
aids in the induction o f an inflammatory response (41). Because IL -ip production is
increased in response to bacterial endotoxin, it was necessary to ascertain if the
administration o f LPS was able to induce IL -ip production in our MM6 cell culture
model. In preparation for use in ELISAs, MM6 cells were grown in serum-containing
media for twenty-four hours and then switched to serum-free media. After seven-hours in
serum-free media, a 500 ng/mL dose o f LPS was administered. MM6 cells were
centrifuged; supemates were harvested and then used in subsequent ELISAs. As shown
in Figure 19A, IL -ip protein levels increased to 115 pg/mL by three-hours after LPS
exposure. The levels o f IL -ip dramatically rose by six and twelve hours to 791 pg/mL IL1P for both time points (extrapolated values).
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Figure 18: Effects of the PAF Receptor Antagonist, WEB2170, on Fold PAF-AH
Induction and PAF-AH Standard Curve. A. MM6 cells were cultured in serumcontaining media for twenty-four hours with 0.5 |xM PAF or 200 ng/mL LPS, alongside
either 50 gM WEB2170 or 15 gM SB203580. WEB2170 was an effective PAF receptor
antagonist and was also able to inhibit the LPS-induced PAF-AH mRNA upregulation.
Administration o f LPS, SB203580 and WEB2170 together decreased PAF-AH mRNA
levels to half those o f control levels. B. Real-Time PCR curves showing differences in
PAF-AH mRNA levels for each noted experimental condition. The data reflect a value
of two independent biological samples analyzed in triplicate; mean difference is
significant at p<0.05. The single asterisk represents statistical significance between PAF

39

and PAF + WEB2170 administration. The double asterisk represents statistical
significance between LPS and LPS + SB203580 administration. The triple asterisk
represents statistical significance between LPS + WEB2170 and LPS + WEB2170 +
SB203580 administration. Error bars represented are +/- standard deviation.

By twenty-four hours, IL -ip protein levels fell to control levels with 169 pg/mL o f IL -ip
protein present. In control cells, IL -ip levels remained relatively constant with a slight
trend o f increasing IL -ip over the twenty-four hour incubation period (15-200 pg/mL).

3.9

TNF-a Induction in Response to LPS Treatment

As mentioned previously, TNF-a is a cytokine involved in acute phase systemic
inflammation. In order to investigate increases in TNF-a protein production as a result of
LPS administration, MM6 cells were cultured as described in the previous section. As
shown in Figure 20, control cells not receiving LPS produced very little TNF-a and
levels detected ranged from 17 pg/mL (time 0) to 43 pg/mL (24-hours) Supemates from
the LPS-induced cells showed a sharp increase by one-hour. TNF-a protein production
reached a maximal 577 pg/mL. After six hours, TNF-a levels began fell to 413 pg/mL
and 253 pg/mL by twelve and twenty-four hours respectively.

3.10

Phospho-p38a Induction in Response to LP S Treatment

Phosphophorylated-p3 8 (p-p38a) is produced in the cell upon activation o f the
p38MAPK portion of the MAPK cascades. This portion o f the MAPK cascade is
activated upon exposure to inflammatory mediators, and various cellular stresses and this
pathway helps to regulate cell differentiation and apoptosis. To determine if the
p38MAPK pathway is indeed activated in MM6 cells, ELISAs against the p-p38a were

40

preformed. (See Figure 21). As described above, MM6 cells were grown in serumcontaining media for twenty-fours then switched to serum-free media.
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Figure 19: IL -ip ELISA. A. MM6 cells were cultured in serum-free media in the
presence o f 500 ng/mL LPS and the conditioned media was collected twenty-four hours
later to be used in ELISAs. IL -ip protein levels begin to increase by thirty-minutes of
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LPS exposure and levels rise substantially by six and twelve hours. Values at six and
twelve hours are extrapolated due to the large induction in IL -ip protein levels at those
time points. IL -ip protein levels begin to increase by three-hours in control conditions
and continue to rise by twenty-four hours. B. Computer generated four-parameter logistic
curve fit showing correlation. The data reflect a value o f two independent biological
samples analyzed in duplicate; mean difference is significant at p<0.01. The single
asterisk represents statistical difference between the six and twelve hour time points
compared to the corresponding control time points. Error bars represented are +/standard deviation.
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Figure 20; TNF-a ELISA. A. MM6 cells were cultured in serum-free media in the
presence o f 500 ng/mL LPS and the conditioned media was collected twenty-four hours
later to be used in ELISAs. Incremental increases in TNF-a protein were observed, upon
administration o f 500 ng/mL LPS, with maximal protein levels present at six-hours.
Subsequent to this time point, levels begin to fall steadily. Control levels remain
relatively steady throughout the time course. B. Computer generated four-parameter
logistic curve fit showing correlation. The data reflect a value o f two independent
biological samples analyzed in duplicate; mean difference is significant at p<.001. The
single asterisk represents a statistical difference between the one through twenty-four
hour time points compared to the corresponding control time points. Error bars
represented are +!- standard deviation.

Cell pellets were resuspended in cell lysis buffer to give a density o f 10^ cells/mL. Before
use in ELISAs, a series o f two, six-fold dilutions were prepared. An analysis o f the pp38a ELISA demonstrated a statistically significant increase in the amount o f p-p38a
protein at one and three hours compared to controls. (1.3 ng p-p38a/ 10^ cells vs. 1.0 ng
p-p38a/ 10^; 1.1 ng p-p38a/ 10^ vs. 1.4 ng p-p38a/ 10^) Subsequent to this time, p-p38a
levels decrease to .78 ng p-p38a/10^ cells by twenty-four hours. Control levels o f p-p38a
fluctuate between .99 and 1.4 ng p-p38a/10^ cells over the entire twenty-four hour time
course.
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Figure 21: p-p38a ELISA. A. MM6 cells were cultured in serum-free media for twenty
four hours in the presence of 500 ng/mL LPS. Cells were harvested, centrifuged and cell
pellets were lysed in cell lysis buffer to give a density o f 10^ cells/mL to be used in
ELISAs. A statistical difference in p-p38a protein levels is observed between the one and
three hour time points. B. Computer generated four-parameter logistic curve fit showing
correlation. The data reflect a value o f two independent biological samples analyzed in
duplicate; mean difference is significant at p<0.05. The single asterisk represents
statistical difference between the one and three hour time points compared to the
corresponding control time points. Error bars represented are +/- standard deviation.
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3.11

Reactive Oxygen Species Induced Upregulation o f PAF-AH mRNA

Because o f the results depleted in Figures 10 and 11, we hypothesized that reactive
oxygen species (ROS) may induce PAF aeetylhydrolase mRNA production. To
investigate this possibility, 100 pM tert- butyl hydroperoxide (TBHP), an inducer of
ROS, was administered to MM6 cells in serum-eontaining media for twenty-four hours.
The cells were harvested, RNA isolated, reverse transcribed to eDNA and analyzed via
Real-Time PCR. Real-Time PCR showed near control levels o f PAF aeetylhydrolase
mRNA for the initial twelve hours; however, at twenty-four hours TBHP exposure
produced a 2.5-fold increase in PAF. (See Figure 22).

3.12 Morphological Changes in MM 6 cells in Response to Singly and Dually
Administered Proinjlammatory Mediators
While inducing inflammatory responses in MM6 cells, various morphological changes,
specifically

cell clumping, were observed during the incubation times.

These

morphological changes may have physiological relevance. Since infiltration from the
vasculature to the injured tissues is a necessary action to mediate an inflammatory
response, expression of various adhesion molecules may play a beneficial role in this
regard. As shown in Figures 23A and 23B, the degree of cell clumping roughly parallels
the fold induction o f PAF-aeetylhydrolase mRNA levels in response to these mediators.
LPS-treated MM6 cells showed the greatest extent in cell clumping compared to TNF-a
and PAF alone. Dual administration o f proinflammatory mediators showed greater cell
clumping compared to the singly administered proinflammatory mediators. LPS 4- TNF-a
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appeared to demonstrate the greatest degree o f cell clumping followed by PAF + LPS and
TNF-a + PAF.

TBHP Induction of PAF Aeetylhydrolase Expression

I
Hours

Figure 22: ROS induced Upregulation of PAF-AH mRNA. MM6 cells were cultured
in serum-containing media in the presence o f 100 pM tert- butyl hydroperoxide for
twenty-four hours. Near control levels o f PAF aeetylhydrolase mRNA induction are
observed for the first twelve with a 2.5 fold increase in PAF aeetylhydrolase mRNA
levels at twenty-four hours. The data reflect a value o f two independent biological
samples analyzed in triplicate; mean difference is significant at p<0.05. The single
asterisk represents statistical significance from the control. Error bars represented are +/standard deviation.
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Figure 23: Morphological Changes in MM6 Cells After Administration of Various
Proinflammatory Mediators. A. Effects o f various proinflammatory mediators on the
morphological changes in MM6 cells. B. Effects o f dually administered proinflammatory
mediators on MM6 cells.
MM6 cells were incubated with the above listed
proinflammatory mediators and combinations therein for twenty-four hours. LPS was
administered at 200 ng/mL. PAF was administered at a concentration o f 0.5pM. TNF-a
was administered at a concentration o f 10 ng/mL. The degree o f cell clumping for the
singly and dually administer mediators roughly parallels the extent o f PAF
aeetylhydrolase mRNA upregulation. Total magnification shown is at 50X.
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CHAPTER 4

DISCUSSION
4.1

Analysis o f Results

The goal o f this study was to investigate PAF aeetylhydrolase expression in
response to both TNF-a and PAF and elucidate any similarities or differences that this
response may have with respect to the EPS-induced response. TNF-a and PAF are known
inflammatory mediators; however, it was not known whether these mediators would be
able to affect PAF aeetylhydrolase expression. In order to investigate this possibility,
dose response experiments were performed. With increasing concentrations o f LPS, PAF
or TNF-a, MM6 cells were exposed to the various concentrations for twenty-four hours
in serum-containing media and the level o f PAF aeetylhydrolase mRNA was analyzed
through Real-Time PCR experiments. Dose response experiments indeed showed the
ability for both TNF-a and PAF (like LPS) to upregulate PAF aeetylhydrolase
expression. (See Figures 7-9). LPS showed the greatest ability to induce PAF
aeetylhydrolase mRNA levels followed by TNF-a and PAF. Increasing concentrations o f
both LPS and TNF-a resulted in increasing levels o f PAF aeetylhydrolase mRNA.
However, the PAF dose response did not appear dose dependent. For all concentrations
of PAF administered, an approximately three-fold increase over PAF aeetylhydrolase
levels was observed. This observation is most likely the result o f the presence o f PAF
aeetylhydrolase in the fetal bovine serum (FBS) that rapidly inactivates PAF. Thus, only
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a portion o f PAF is available to bind the receptor and signal. The wide variation
observed in PAF aeetylhydrolase expression levels (2-20-fold), for all presented dose
responses, induced by the various mediators, demonstrates that the PAF aeetylhydrolase
gene is highly regulated rather than “on or off.” This observation hints that varying levels
o f PAF aeetylhydrolase are induced contingent upon the degree o f inflammation present
in the host. Previous work by Howard et al. demonstrated upregulation o f PAF
aeetylhydrolase in rats exposed to LPS (32). Furthermore, the increased expression was
detected solely in Kupffer cells, the resident macrophages o f the liver. We have
successfully reproduced the in vivo macrophage response to LPS in our cultured MM6
cells. Since PAF and TNF-a are capable o f inducing PAF aeetylhydrolase expression in
the MM6 cells, this likely represents a physiologically relevant response that would be
seen in vivo.
Our data in MM6 cells are in good agreement with that by Howard et al. that
demonstrated maximal induction o f PAF aeetylhydrolase mRNA and protein via in vivo
LPS administration in the liver sinusoidal cells o f rats at twenty-four hours (32) (42).
Further, in our work, LPS, PAF and TNF-a were able to upregulate PAF aeetylhydrolase
mRNA expression beginning at around 12-hours, with both TNF-a and LPS-indueed
PAF aeetylhydrolase mRNA levels peaking at twenty-four hours. (See Figures 10-13).
However, the PAF induced response continued to increase at both forty-eight and
seventy-two hours. This time frame for PAF aeetylhydrolase induction agrees with what
is seen in vivo (42). The LPS-indueed upregulation o f PAF aeetylhydrolase mRNA is
mediated by interaction o f LPS with LPS binding protein (LBP) present in the serum.
LPS and LBP form a complex which delivers the LPS to CD 14, a eell surfaee reeeptor.
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The new LPS-CD14 eomplex then interacts with a member o f the toll-like receptor super
family ealled TLR-4. The aetivation of TLR-4 initiates signaling through the MAPK
cascades as shown in Figure 5 (31). Experiments were preformed to determine if EBP is
required for the EPS-induced expression o f PAF aeetylhydrolase. In the presenee o f 10%
FBS, and henee EBP, a 10-20 fold increase in PAF aeetylhydrolase expression was
detected after the addition o f EPS. Control eells not reeeiving EPS, demonstrated low
constitutive levels o f PAF aeetylhydrolase mRNA as shown in Figure 10. In the absenee
o f serum, PAF aeetylhydrolase levels also increased with time. Surprisingly, this inerease
was deteeted in eells that did and did not reeeive EPS. (See Figure 11). This EPSindependent response was partieularly robust at forty-eight and seventy-two hours where
an over thirty and sixty-fold inerease in PAF aeetylhydrolase mRNA levels was deteeted
respeetively.
Beeause PAF aeetylhydrolase mRNA expression was indueed under the serumfree eonditions, regardless o f EPS administration, we were unable to equivoeally
determine if EBP is required for EPS signaling. However, no statistieally signifieant
differenees were detected in the magnitude o f induetion between EPS-treated and eontrol
eells. This either represents the faet that EPS requires the presenee o f EBP for signaling
or that the EPS-independent induetion is so large that it is masking any solely EPSmediated effeets.
MM6 eells eultured under serum-free eonditions begin to deteriorate in
morphologieal appearance and viability beginning around twenty-four hours (Data not
shown). By seventy-two hours, over 50% o f the eell population is non-viable. Clearly,
environmental stress indueed by eell starvation for prolonged periods, dramatieally
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induced PAF aeetylhydrolase mRNA expression. During times o f environmental stress,
ROS levels can increase dramatieally. Therefore, it is possible that the large extent of
PAF aeetylhydrolase induetion in serum-free eonditions at forty-eight and seventy-two
hours may be the result o f generation o f ROS. Kulisz et al. have shown that ROS inerease
the amount o f p-p38a (43). Thus, an induction in ROS may be responsible for the large
increase in PAF aeetylhydrolase mRNA levels observed both at the forty-eight and
seventy-two hour time points in serum-free media. To a slight extent, these ROS may
also generate an uncontrolled production o f PAF-like phospholipids that can also
upregulate PAF aeetylhydrolase mRNA levels.
To investigate if ROS are capable o f inducing the PAF aeetylhydrolase message,
we administered a ROS inducer, tert-huiy\ hydroperoxide (TBHP) at 100 pM. TBHB
administration resulted in a 2.5-fold inerease in PAF aeetylhydrolase expression at
twenty-four hours This result clearly demonstrated that ROS can indeed induce
expression o f PAF aeetylhydrolase. However, additional experiments are required to
assay for induetion at the forty-eight and seventy-two hour time points. Further, the 2.5fold induction upon 100 pM TBHP did not recapitulate the thirty and sixty-fold induetion
observed at the forty-eight and seventy-hour time points for cultured MM6 eells in
serum-free media. This may be due to insufficient production o f ROS. Dose response
experiments with TBHP may help determine the effective concentrations to recapitulate
the serum-free RPMI result. Further, LPS is able to induce the formation o f superoxide
radicals in alveolar macrophages and other phagocytes as part o f the immune system
mechanism o f killing pathogens (44). The faet that ROS are able to induce the expression

52

o f PAF aeetylhydrolase makes logical sense to hydrolyze any oxidized phospholipids that
can be formed.
To elucidate any similarities in signaling between LPS, TNF-a, and PAF, the
proinflammatory mediators were administered in various combinations. Administration
o f TNF-a and LPS together stimulated PAF aeetylhydrolase expression far greater than
TNF-a or LPS alone. This observed effect was greater than what would be predicted from
just an additive response. The synergism detected between TNF-a

and LPS suggests

TNF-a activates signaling pathways that influence the response to LPS (i.e. cross-talk).
In contrast, the PAF aeetylhydrolase induction in response to LPS plus PAF and TNF-a
plus PAF was approximately additive. This observation suggests the activation o f parallel
but independent pathways that result in stimulated PAF aeetylhydrolase expression.
Because o f these observations, and the importance o f the MAPK pathways in
inflammatory responses, the roles o f the various portions o f the MAPK pathways were
investigated.
Examination o f the MAPK pathways that were important in the EPS-mediated
upregulation o f PAF aeetylhydrolase showed predominant signaling through the p38
portion o f the MAPK pathway marked by 50% inhibition from SB203580. (Figure 15).
For TNF-a- treated MM6 cells, inhibition o f the p38MAPK pathway showed a 20%
decrease in PAF aeetylhydrolase induction that was found not to be statistically
significant. This indicates only a minor role for the p38MAPK pathway in TNF-a
signaling. Similar to the TNF-a response, the PAF-induced induction o f PAF
aeetylhydrolase was also decreased by approximately 20% in the presence o f SB203580;
however, this decrease was not statistically significant (Figure 17). These data show a
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significant difference in the signaling between LPS compared to TNF-a/PAF signaling.
In these presented experiments, inhibition with SP600125, an inhibitor o f the INK
portion o f the pathway was not investigated— although the IN K inhibitor does not alter
the LPS-indueed expression (data not shown).

To further elucidate the predominant

signaling pathways involved in TNF-a and PAF signaling with the dual administration o f
inhibitors must be performed
Interestingly, inhibition o f the ER K l/2 MAPK showed a 50% increase in PAF
aeetylhydrolase production over the induction elicited by the pro-inflammatory mediators
alone (LPS, TNF-a, and PAF). (See Figures 16 and 17). Additionally, inhibition o f
ER K l/2 by itself resulted in a small but significant increase in PAF aeetylhydrolase
levels. This result may be explained by the fact that the MAPK pathways play diverse
roles in signaling that regulate cell proliferation, differentiation, gene expression and cell
survival (45). Specifically, the ER K l/2 portion o f the MAPK pathway regulates cell
differentiation and proliferation. Thus, inhibition o f this pathway may impose a further
stress on the cell which results in slight activation o f p38MAPK and thus increased PAF
aeetylhydrolase levels.
Stafforini et al. have shown that EPS-induced PAF aeetylhydrolase induction is
solely mediated through the p38 portion o f the MAPK pathway in THP1/CD14 cells (40).
Our work in MM6 cells showed 5(3% inhibition o f PAF aeetylhydrolase mRNA induction
upon exposure to SB203580— the p38MAPK inhibitor. Interestingly, Howard et al.
demonstrated the PAF receptor antagonist, WEB2170, was able to downregulate the in
vivo LPS-indueed upregulation o f PAF aeetylhydrolase in rats by 50% (36). Thus, these
separate observations prompted experiments to détermine the effects o f dually
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administered SB203580 and WEB2170. The PAF receptor antagonist, WEB2170, was
administered prior to stimulation with LPS or PAF. As expected, WEB2170 is an
effective PAF receptor antagonist and able to inhibit the PAF-induced response. LPSindueed upregulation o f PAF aeetylhydrolase mRNA was inhibited by approximately
50% by the PAF receptor antagonist. Importantly, dual administration o f SB203580 in
conjunction with WEB2170 completely abolished PAF aeetylhydrolase induction. Our
data

strongly

support

our

contention

that

the

remaining

LPS-indueed

PAF

aeetylhydrolase mRNA levels present after SB203580 administration are the result of
increased PAF production and signaling instigated by LPS administration. Our findings
are in contrast with the work o f Stafforini et al. in that the LPS-mediated upregulation of
PAF aeetylhydrolase is solely p38MAPK dependent. Although not examined, it would be
interesting to determine if the effects of TNF-a are also partly mediated via PAF
biosynthesis and PAF-receptor activation. TNF-a is capable o f stimulating PAF synthesis
in monocytes (46).
In order to gain a more thorough understanding o f the inflammatory response in
MM6 cells, ELISAs for IL -lp, TNF-a and p-p38a were performed. (See Figures 19-21).
hese experiments were performed in serum-free media to assay for the secreted
cytokines. Because o f the absence o f serum in the media and thus a lack o f LBP, a 500
ng/mL LPS dose was administered to ensure signaling through TLR-4. Cell lysates and
conditioned media exposed to LPS were harvested and used in various ELISAs. The
ELISAs showed the ability of MM6 cells to mount an inflammatory response to LPS and
secrete various cytokines such as TNF-a and IL -ip. Because the PAF receptor
antagonists partly inhibited the LPS-indueed upregulation of PAF aeetylhydrolase, we
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concluded that the proinflammatory mediator PAF is .also being produced. Maximal
induction o f IL -ip or TNF-a protein occurred between six and twelve hours. In our
experiments examining PAF aeetylhydrolase mRNA, maximal levels were observed by
twenty-four hours (Figures 10, 12 and 13). This delayed responsiveness in PAF
aeetylhydrolase induction most likely reflects the need to control and limit PAF and PAFlike mediator production at this later stage. In other words, initial PAF production is a
beneficial response, but left unchecked, can lead to unwanted effects. The induction of
PAF aeetylhydrolase at twenty-four hours most likely serves to limit the damage that can
occur during an inflammatory response and helps promote recovery o f the host.
Statistically significant differences in p-p38a by one hour and three hours show
that LPS is indeed signaling through the p38 portion o f the MAPK pathway— further
advancing the hypothesis that LPS signals at least in part through p38MAPK. However,
at time points other than one and three hours, no statistical differences were seen. A
repeat o f this ELISA is necessary in order to clarify this result and gain a more thorough
understanding.
There are numerous signaling pathways that are linked to the PAF receptor
activation and this may explain the many PAF-induced biological responses o f various
cell types. PAF stimulates the expression o f adhesion molecules and various cell surface
receptors, when the PAF receptor is stimulated (47,48).

In our experiments,

administration o f LPS, PAF and TNF-a and combinations thereof showed marked
morphological changes in the MM6 cells, specifically cell clumping. (See Figures 23A
and 23B). This observation may have physiological relevance. Monocytes express the
ligand for P selectin, P selectin glycoprotein ligand-1, which aids in adhesive interactions

56

with both endothelial cells and platelets (47). Such expression is relevant since
infiltration from the vasculature into the tissue is necessary in an inflammatory response
to rid the infected area of invading microorganisms or necrotic tissue. Exactly how LPS,
TNF-a and PAF are producing MM6 cell clumping remains to be demonstrated.

4.2 Conclusions and further Work
This research has shown the various signaling pathways that are important in
inducing the upregulation o f the plasma form of PAF aeetylhydrolase. We have
demonstrated that in addition to LPS, TNF-a and PAF are able to upregulate PAF
aeetylhydrolase expression with LPS being the most potent inducer followed by TNF-a
and PAF. We have also demonstrated that 50% o f the observed LPS-indueed
upregulation o f PAF aeetylhydrolase is the result of PAF signaling through its reeeptor.
Though the LPS-indueed response is partly p38MAPK dependent, the induction observed
for both TNF-a and PAF is not. The TNF-a and PAF-induced induction o f PAF
aeetylhydrolase levels may be the result o f increased PAF synthesis upon administration
of these mediators or signaling through a separate pathway(s). In these studies, the role of
the JNK portion o f the MAPK pathway was not investigated. Further work is necessary
to elucidate the role that this pathway may have with TNF-a or PAF signaling.
Additionally, the 50% induction in PAF aeetylhydrolase mRNA levels (relative to
the inflammatory mediator administered) after administration o f the ER K l/2 inhibitor
requires further investigation. Performing ELISAs, speeifie for p-p38a protein, and
assays for ROS will help answer the question whether cellular stresses, increased
activation o f p38MAPK, or both occur in the presenee of PD98059. W ork by Kulisz et al.
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supports our hypothesis that eellular stresses, speeifieally ROS, ean inerease p38MAPK
aetivation (43). Our work with TBHP has shown the ability o f ROS to induee PAF
aeetylhydrolase levels. Whether this is p38MAPK-dependent in MM6 eells still requires
further elueidation.
In eonelusion, we have demonstrated that LPS, TNF-a, and PAF are able to
induee PAF aeetylhydrolase expression and have gained a greater understanding in
regulation o f PAF aeetylhydrolase expression. The inereases in PAF aeetylhydrolase
levels, in response to numerous mediators, likely represent the physiologieal requirement
to eurb the progression o f the inflammatory response and maintain the viability o f the
host. Thus, the work presented here furthers our knowledge concerning the roles played
by the plasma PAF aeetylhydrolase in the inflammatory process.
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